Hermetica Superfood Encyclopedia
The Short Answer
Amazonian Cinnamon (Cinnamomum parvicompactum) contains cinnamaldehyde as its primary bioactive compound, which inhibits NF-κB and AP-1 transcription factors while activating Nrf2 pathways. The bark demonstrates anti-inflammatory, antioxidant, and glucose-regulating properties through modulation of cellular signaling cascades.
CategoryBark
GroupBark
Evidence LevelStrong
Primary Keywordamazonian cinnamon benefits
Synergy Pairings4
Health Benefits
Regulates blood sugar levels and improves insulin sensitivity through cinnamaldehyde and polyphenol activity.
Enhances cardiovascular health and circulation by improving vascular function and lowering LDL cholesterol.
Reduces inflammation and alleviates pain through bioactive anti-inflammatory compounds.
Promotes digestive health by supporting gut microbiota balance and relieving bloating.
Strengthens immune function and protects against oxidative damage with flavonoids, tannins, and essential oils.
Enhances cognitive function by improving memory, focus, and reducing neuroinflammation.
Origin & History
Amazonian Cinnamon, derived from various *Cinnamomum* species native to the Amazon rainforest, is a distinct botanical with a rich history in indigenous traditions. It is valued for its unique profile of cinnamaldehyde and polyphenols, offering significant benefits for metabolic, cardiovascular, and cognitive health.
“Amazonian Cinnamon has been historically used by Indigenous Amazonian tribes for centuries. It was traditionally brewed into herbal tonics and decoctions for regulating blood sugar, improving circulation, supporting digestion, and enhancing metabolic vitality within their communities.”Traditional Medicine
Scientific Research
Scientific studies, including in vitro and animal research, highlight Amazonian Cinnamon's potential in blood sugar regulation, cardiovascular support, and anti-inflammatory action. Research is ongoing to further validate its traditional uses and explore its full spectrum of benefits in human clinical trials.
Preparation & Dosage
Extract Form
000 mg of Amazonian cinnamon extract daily for metabolic and cardiovascular support
500–1,.
Powdered Form
1–2 grams of powder for digestive and anti-inflammatory benefits, often consumed in teas or foods.
Traditional Use
Historically brewed into herbal tonics and decoctions by Indigenous Amazonian tribes.
Nutritional Profile
- Cinnamaldehyde: Key bioactive compound for metabolic and anti-inflammatory effects.
- Polyphenols, Flavonoids, Tannins: Potent antioxidants and anti-inflammatory agents.
- Essential Oils, Terpenes: Contribute to aromatic profile and therapeutic properties.
How It Works
Mechanism of Action
Cinnamaldehyde, the predominant compound in Amazonian Cinnamon bark, inhibits NF-κB and AP-1 transcription factors to suppress inflammation, proliferation, and angiogenesis. The compound activates Nrf2 pathways for antioxidant effects while improving glucose uptake and insulin sensitivity. Additional bioactive compounds including eugenol, procyanidin B2, and epicatechin contribute to cardiovascular protection through improved vascular function.
Clinical Evidence
Current evidence for Amazonian Cinnamon is primarily based on preclinical in vitro and animal studies, with limited human clinical trials available. In rat Parkinson's models, cinnamon extracts increased striatal dopamine by 17-49% and reduced oxidative stress markers by 15-22%. Antioxidant studies show IC50 values of 1.771 mg/mL for DPPH and 0.060 mg/mL for ABTS radical scavenging. Human clinical trials are needed to validate these preclinical findings and establish therapeutic dosages.
Safety & Interactions
Safety data specific to Amazonian Cinnamon is limited, with most research focusing on preclinical models. The poor aqueous solubility of cinnamaldehyde may limit bioavailability in therapeutic applications. Nrf2 activation, while generally beneficial, may potentially promote survival in established tumors or contribute to treatment resistance. Pregnant and nursing women should avoid use due to insufficient safety data, and patients on diabetes or cardiovascular medications should consult healthcare providers before use.
Synergy Stack
Hermetica Formulation Heuristic
Polyphenol/antioxidant base
Cardio & Circulation | Gut & Microbiome
Featured in
Cozy
Warming adaptogenic blend for comfort and calm.
Shop Now →
Also Known As
Cinnamomum parvicompactumWild Amazon CinnamonAmazonian CassiaRainforest Cinnamon
Frequently Asked Questions
How does Amazonian Cinnamon differ from regular cinnamon?
Amazonian Cinnamon (Cinnamomum parvicompactum) is distinct from common Ceylon cinnamon (C. verum) or Cassia cinnamon (C. cassia) in its unique bioactive profile and Amazonian origin. While sharing cinnamaldehyde as the primary compound, Amazonian varieties may contain different concentrations of secondary metabolites like procyanidin B2 and ethyl cinnamate.
What is the recommended dosage for Amazonian Cinnamon bark?
No standardized dosage exists for Amazonian Cinnamon bark due to limited human clinical trials. Preclinical studies used varying extract concentrations from 100-600 μg/mL in vitro, but therapeutic human dosages require further research. Traditional use suggests 1-3 grams daily, but medical supervision is recommended.
Can Amazonian Cinnamon help with diabetes management?
Preclinical evidence suggests Amazonian Cinnamon may improve glucose uptake and insulin sensitivity through cinnamaldehyde activity. However, human clinical trials are lacking to confirm therapeutic efficacy for diabetes management. Diabetic patients should not substitute prescribed medications without medical consultation.
What are the main bioactive compounds in Amazonian Cinnamon bark?
Amazonian Cinnamon bark contains cinnamaldehyde as the primary bioactive compound, along with caffeic acid, eugenol, procyanidin B2, ethyl cinnamate, β-caryophyllene, epicatechin, and catechin. These compounds work synergistically to provide anti-inflammatory, antioxidant, and metabolic benefits through multiple cellular pathways.
Is Amazonian Cinnamon safe for long-term use?
Long-term safety data for Amazonian Cinnamon is insufficient, with most evidence coming from short-term preclinical studies. The activation of Nrf2 pathways may have complex effects in certain disease states, particularly cancer. Extended use should be monitored by healthcare professionals due to limited human safety data.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
